Linagliptin

Tradjenta

Dipeptidyl Peptidase 4 Inhibitor

NADAC/unit $16.8020

No Shortage Tier 1: 17.6% PA Req: 0.3% 7 Manufacturers 7 ANDAs

JENTADUETO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus .

vs. brand Tradjenta: Generic saves up to -68% per unit

Covered Lives

Generic Manufacturers

AUROBINDO PHARMA LTDBOEHRINGER INGELHEIM PHARMACEUTICALS INCDR REDDYS LABORATORIES LTDINVAGEN PHARMACEUTICALS INCMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INCSUNSHINE LAKE PHARMA CO LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Linagliptin drfinder.aiFind doctors who prescribe Linagliptin rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Linagliptin

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.